Shiro Kitamoto

4.5k citations

52 papers · 3.8k indexed · h-index 31

Impact in

Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
Immunology top 2%
- Atherosclerosis and Cardiovascular Diseases

Papers in

Immunology 21
- Atherosclerosis and Cardiovascular Diseases 16
Cancer Research 14
- Protease and Inhibitor Mechanisms 8

Co-authors: Kensuke Egashira Akira Takeshita Shujiro Inoue Weihua Ni Makoto Usui Ken‐ichi Hiasa Minako Ishibashi Chu Kataoka
Journals: Circulation (8 papers)Hypertension (5 papers)The FASEB Journal (4 papers)Arteriosclerosis Thrombosis and Vascular Biology (4 papers)American Journal of Physiology-Heart and Circulatory Physiology (3 papers)
Partner nations: Japan United States Sweden

In The Last Decade

Shiro Kitamoto

52 papers receiving 3.7k citations

Peers

Countries citing papers authored by Shiro Kitamoto

Since Specialization

Citations

This map shows the geographic impact of Shiro Kitamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Kitamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Kitamoto more than expected).

Fields of papers citing papers by Shiro Kitamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Kitamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Kitamoto. The network helps show where Shiro Kitamoto may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shiro Kitamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shiro Kitamoto Line = papers co-authored together Shiro Kitamoto links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Expression of Chitotriosidase in Macrophages Modulates Atherosclerotic Plaque Formation in Hyperlipidemic Mice Frontiers in Physiology ·Jonathan Yap, Sara McCurdy, Martín Alcalá, A. L. B., Joseph Padden, Giovana Bellettato Reche, Bog‐Hieu Lee, Shiro Kitamoto, William A. Boisvert	2020	10
2	Suppression of abdominal aortic aneurysm formation by AR-R17779, an agonist for the α7 nicotinic acetylcholine receptor Atherosclerosis ·Aya Watanabe, Toshihiro Ichiki, Hiroshi Kojima, H Kalkowska, Eva Hurt‐Camejo, Erik Michaëlsson, Evan R. Farrer, Jiro Ikeda, S. G. C. SILVA, Tomotake Tokunou, Shiro Kitamoto, Kenji Sunagawa	2015	8
3	PPARγ Agonists Attenuate Palmitate-Induced ER Stress through Up-Regulation of SCD-1 in Macrophages PLoS ONE ·Jiro Ikeda, Toshihiro Ichiki, H Kalkowska, Hiroshi Kojima, Evan R. Farrer, Shiro Kitamoto, Tomotake Tokunou, Kenji Sunagawa	2015	45
4	Stimulation of α7 nicotinic acetylcholine receptor by AR-R17779 suppresses atherosclerosis and aortic aneurysm formation in apolipoprotein E-deficient mice Vascular Pharmacology ·Toru Hashimoto, Toshihiro Ichiki, Aya Watanabe, Eva Hurt‐Camejo, Erik Michaëlsson, Jiro Ikeda, S. G. C. SILVA, Hirohide Matsuura, Tomotake Tokunou, Shiro Kitamoto, Kenji Sunagawa	2014	35
5	Chitinase Inhibition Promotes Atherosclerosis in Hyperlipidemic Mice American Journal Of Pathology ·Shiro Kitamoto, Kensuke Egashira, Toshihiro Ichiki, Xinbing Han, Sara McCurdy, Shohei Sakuda, Kenji Sunagawa, William A. Boisvert	2013	22
6	Cystatin C Deficiency Promotes Epidermal Dysplasia in K14-HPV16 Transgenic Mice PLoS ONE ·Weifang Yu, Jian Liu, Michael Shi, Jianan Wang, Meixiang Xiang, Shiro Kitamoto, Bing Wang, Galina K. Sukhova, Gëorge F. Murphy, Gabriela Orasanu, Anders Grubb, Guo‐Ping Shi	2010	24
7	Interleukin-10 Facilitates Both Cholesterol Uptake and Efflux in Macrophages Journal of Biological Chemistry ·Xinbing Han, Shiro Kitamoto, E.S. Klimkina, William A. Boisvert	2009	69
8	Mast cells promote atherosclerosis by releasing proinflammatory cytokines Nature Medicine ·Jiusong Sun, Galina K. Sukhova, Paul J. Wolters, Min Yang, Shiro Kitamoto, Peter Libby, Lindsey A. MacFarlane, Jon Mallen‐St. Clair, Guo‐Ping Shi	2007	334
9	Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor–Knockout Mice Circulation ·Shiro Kitamoto, Galina K. Sukhova, Jiusong Sun, Min Yang, Peter Libby, Issoufou Mamane Abdou, Paurene Duramad, Chongxiu Sun, Yadong Zhang, Galina A. Avdiyuk, Christoph Peters, Guo‐Ping Shi	2007	113
10	Cathepsin S Controls Angiogenesis and Tumor Growth via Matrix-derived Angiogenic Factors Journal of Biological Chemistry ·Bing Wang, Jiusong Sun, Shiro Kitamoto, Min Yang, Anders Grubb, Harold A. Chapman, Raghu Kalluri, Guo‐Ping Shi	2005	229
11	Endothelial Dysfunction and Coronary Atherosclerosis PubMed ·Shiro Kitamoto, Kensuke Egashira	2004	14
12	Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor Basic Research in Cardiology ·Ken‐ichi Hiasa, Kensuke Egashira, Shiro Kitamoto, Minako Ishibashi, Shujiro Inoue, Weihua Ni, Qingwei Zhao, K Kimizima, Makoto Katoh, Masataka Sata, Akira Takeshita	2004	45
13	Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys Gene Therapy ·Kisho Ohtani, Makoto Usui, Kazuya Nakano, Ruth E. Channell, Pooja Swaroop Kulashreshta, Yasuhiko Hirouchi, S.M. Rytov, Shiro Kitamoto, Akira Takeshita, K Egashira	2004	40
14	Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice American Journal of Physiology-Lung Cellular and Molecular Physiology ·Ichiro Inoshima, Kazuyoshi Kuwano, Naoki Hamada, Naoki Hagimoto, Michihiro Yoshimi, Takashige Maeyama, Akira Takeshita, Shiro Kitamoto, Kensuke Egashira, Nobuyuki Hara	2004	112
15	Critical Role of Monocyte Chemoattractant Protein-1 Receptor CCR2 on Monocytes in Hypertension-Induced Vascular Inflammation and Remodeling Circulation Research ·Minako Ishibashi, Ken‐ichi Hiasa, Qingwei Zhao, Shujiro Inoue, Kisho Ohtani, Shiro Kitamoto, Miyuki Tsuchihashi, Takeshi Sugaya, Israel Charo, Shinobu Kura, Teruhisa Tsuzuki, Tatsuro Ishibashi, Akira Takeshita, Kensuke Egashira	2004	190
16	HMG-CoA Reductase Inhibitor Limits Angiotensin II-Induced Progression and Destabilization of Established Atherosclerosis in ApoE-Knockout Mice through Its Cholesterol-Lowering Independent Actions Japanese Circulation Journal-english Edition ·Shiro Kitamoto, Kensuke Egashira, Weihua Ni, Qingwei Zhao, Shujiro Inoue, Ken‐ichi Hiasa, Minako Ishibashi, Kisho Ohtani, Akira Takeshita	2003	2
17	Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases Expert Review of Cardiovascular Therapy ·Shiro Kitamoto, Kensuke Egashira	2003	21
18	Stress and Vascular Responses: Anti-inflammatory Therapeutic Strategy Against Atherosclerosis and Restenosis After Coronary Intervention Journal of Pharmacological Sciences ·Shiro Kitamoto, Kensuke Egashira, Akira Takeshita	2003	23
19	Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Limits Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E-Knockout Mice Japanese Circulation Journal-english Edition ·Weihua Ni, Kensuke Egashira, Shiro Kitamoto, Makoto Usui, Shujiro Inoue, Nai-Hsuan Lin, Minako Ishibashi, Ken‐ichi Hiasa, Chu Kataoka, Toshihiro Ichiki, Akira Takeshita	2002	1
20	Anti-monocyte chemoattractant protein-1 gene therapy inhibits neointimal hyperplasia after balloon angioplasty in rats and monkeys Japanese Circulation Journal-english Edition ·Makoto Usui, Kensuke Egashira, Kisho Ohtani, Chu Kataoka, Ken‐ichi Hiasa, Minako Ishibashi, Shujiro Inoue, Shiro Kitamoto, Weihua Ni, Qingwei Zhao, Akira Takeshita	2002	1

About Shiro Kitamoto

Shiro Kitamoto is a scholar working on Immunology, Cancer Research, Biochemistry, Immunology and Allergy and Cardiology and Cardiovascular Medicine, having authored 52 papers that have together received 3.8k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (16 papers), Nitric Oxide and Endothelin Effects (8 papers), Protease and Inhibitor Mechanisms (8 papers), Eicosanoids and Hypertension Pharmacology (6 papers), Angiogenesis and VEGF in Cancer (6 papers), Renin-Angiotensin System Studies (6 papers), Chemokine receptors and signaling (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). The work is most often cited by research in Immunology and Allergy (361 citations), Immunology (1.2k citations), Cancer Research (608 citations), Cardiology and Cardiovascular Medicine (713 citations) and Oncology (622 citations). Shiro Kitamoto has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Kensuke Egashira, Akira Takeshita, Shujiro Inoue, Weihua Ni, Makoto Usui, Ken‐ichi Hiasa, Minako Ishibashi, Chu Kataoka, Masamichi Koyanagi and Qingwei Zhao. Their work appears in journals such as Circulation, Hypertension, The FASEB Journal, Arteriosclerosis Thrombosis and Vascular Biology and American Journal of Physiology-Heart and Circulatory Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact